Citizens & Northern Corp Biogen Inc. Transaction History

Citizens & Northern Corp

$331 Million
Q3 2024

A detailed history of Citizens & Northern Corp transactions in Biogen Inc. stock. As of the latest transaction made, Citizens & Northern Corp holds 4,222 shares of BIIB stock, worth $618,396. This represents 0.25% of its overall portfolio holdings.

Number of Shares

4,222

Previous 4,352 2.99%

Holding current value

$618,396

Previous $1.01 Million 18.85%

% of portfolio

0.25%

Previous 0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$189.07 - $236.8 $24,579 - $30,784	-130 Reduced 2.99%	4,222 $818,000
Q2 2024 Jul 30, 2024	SELL	$190.52 - $236.72 $28,387 - $35,271	-149 Reduced 3.31%	4,352 $1.01 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $20,565 - $25,967	97 Added 2.2%	4,501 $970,000
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $42,292 - $50,908	-190 Reduced 4.14%	4,404 $1.14 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $33,182 - $37,451	-131 Reduced 2.77%	4,594 $1.18 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $44,040 - $50,889	-160 Reduced 3.28%	4,725 $1.35 Million
Q1 2023 May 05, 2023	BUY	$256.56 - $292.34 $6,157 - $7,016	24 Added 0.49%	4,885 $1.36 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $45,439 - $55,209	180 Added 3.85%	4,861 $1.35 Million
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $1,362 - $1,879	7 Added 0.15%	4,681 $1.25 Million
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $876,561 - $1.04 Million	4,674 New	4,674 $953,000
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $729,390 - $925,241	-2,713 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $44,452 - $61,422	-202 Reduced 6.93%	2,713 $805,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $16,308 - $18,291	-75 Reduced 2.51%	2,915 $679,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $22,367 - $24,655	-102 Reduced 3.3%	2,990 $699,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $36,840 - $57,623	-170 Reduced 5.21%	3,092 $731,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $3,899 - $4,938	14 Added 0.43%	3,262 $982,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $395,651 - $517,402	-1,348 Reduced 29.33%	3,248 $1.15 Million
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $12,103 - $14,424	47 Added 1.03%	4,596 $1.33 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $14,567 - $20,602	-56 Reduced 1.22%	4,549 $1.25 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $227,345 - $254,644	-739 Reduced 13.83%	4,605 $1.47 Million
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $68,600 - $80,444	-244 Reduced 4.37%	5,344 $1.67 Million
Q2 2017 Aug 11, 2017	BUY	N/A	5,588	5,588 $1.52 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens & Northern Corp, based on Form 13F filings with the SEC.

News

Stay updated on Citizens & Northern Corp with notifications on news.

Account

Citizens & Northern Corp Biogen Inc. Transaction History